OneStim™ CRM
The OneStim-CRM™ provides, in one device, the key functionality recommended for implanting conduction system pacing leads according to the 2023 EHRA clinical consensus statement on conduction system pacing implantation [1], namely:
- Voltage controlled pacing
- Continuous impedance measurements
- Current of Injury display, and
- 12 Lead ECG display and measurement.
Features
Continuous impedance with graph
Full 12 ECG display
Trigger screen with automatic measurements - RWPT, V6-V1 Int
Paced extras
Template comparison
Review screen with multiple callipers
OneStim™ CRM Specifications
Patient Interface
- 2 intra-cardiac channels
- 12-13 lead surface ECG
- 1 independent emergency pacing channel
Programmable Stimulation
- Pace, A-V Delay, Nodal ERP, R-synced Sx, Threshold
- 0.1-25V (50V in esophageal mode)
- 0.1-25mA
ECG Analysis & Recording
- Up to 90s buffer of saved ECG for review at sweep speed up to 400mm/s
- Time and amplitude measurement callipers (±1ms, ±0.1mV)
- Triggered sweep
- Template comparison
- Save printable reports
Training Videos
Reference: [1] Burri, H., Jastrzebski, M., Cano, Ó., Čurila, K., de Pooter, J., Huang, W., Israel, C., Joza, J., Romero, J., Vernooy, K., Vijayaraman, P., Whinnett, Z., & Zanon, F. (2023). EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace, 25(4), 1208–1236.
Micropace EP Inc. – United States
3205 West Warner Ave
Santa Ana, CA 92704
United States
Phone: +1 (714) 258 7025
Fax: +1 (714) 258 7280
Email: support@micropaceep.com
Micropace Pty Ltd – Australia
Unit 41, 159 Arthur Street
Homebush West, NSW 2140 Australia
Phone: +61 2 9718 1746
Email: support@micropace.com.au
Micropace EU s.r.o. – Czech Republic
Kroftova 329/1
150 00 Praha 5
Czech Republic
Phone: +420 776 714 941
Email: support@micropace.eu